Related references
Note: Only part of the references are listed.Impact of c-MYC expression on proliferation, differentiation, and risk of neoplastic transformation of human mesenchymal stromal cells
Svitlana Melnik et al.
STEM CELL RESEARCH & THERAPY (2019)
Long Chain Non-Coding RNA (lncRNA) HOTAIR Knockdown Increases miR-454-3p to Suppress Gastric Cancer Growth by Targeting STAT3/Cyclin D1
Datong Jiang et al.
MEDICAL SCIENCE MONITOR (2019)
Reciprocal regulations between miRNAs and HIF-1α in human cancers
Wanli Yang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression
Ziyue Chen et al.
MOLECULAR THERAPY (2019)
Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy
Kewei Xie et al.
CELL DEATH & DISEASE (2019)
YAP Promotes VEGFA Expression and Tumor Angiogenesis Though Gli2 in Human Renal Cell Carcinoma
Shan Xu et al.
ARCHIVES OF MEDICAL RESEARCH (2019)
Cancer Screening in the United States, 2018: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening
Robert A. Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A role for Hippo/YAP-signaling in FGF-induced lens epithelial cell proliferation and fibre differentiation
L. J. Dawes et al.
EXPERIMENTAL EYE RESEARCH (2018)
The Hippo Signaling Network and Its Biological Functions
Jyoti R. Misra et al.
ANNUAL REVIEW OF GENETICS, VOL 52 (2018)
Coxsackievirus A6 Induces Cell Cycle Arrest in G0/G1 Phase for Viral Production
Zengyan Wang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Ovarian cancer: epidemiology and risk factors
Carlo La Vecchia
EUROPEAN JOURNAL OF CANCER PREVENTION (2017)
Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter
Dian-gang Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Genetic polymorphisms in cyclin D1 are associated with risk of renal cell cancer in the Chinese population
Jianxin Xue et al.
ONCOTARGET (2017)
The MYCN Protein in Health and Disease
Maria Victoria Ruiz-Perez et al.
GENES (2017)
The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis
Yuhang Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis
Rafael Kramann et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
MicroRNA: a new target for improving plant tolerance to abiotic stress
Baohong Zhang
JOURNAL OF EXPERIMENTAL BOTANY (2015)
Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer
Silvia Pineda et al.
PLOS GENETICS (2015)
HIF2α is associated with poor prognosis and affects the expression levels of survivin and cyclin D1 in gastric carcinoma
Wei-Wei Tong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer
M. L. King et al.
ONCOGENE (2015)
Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer
Masaki Mori et al.
CELL (2014)
Genetic Variants in the Fibroblast Growth Factor Pathway as Potential Markers of Ovarian Cancer Risk, Therapeutic Response, and Clinical Outcome
Qing H. Meng et al.
CLINICAL CHEMISTRY (2014)
YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
Yan Xia et al.
PLOS ONE (2014)
Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study
Martha L. Slattery et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Immunohistochemical Expression of Cyclin D1, p16Ink4a, p21WAF1, and Ki-67 Correlates With the Severity of Cervical Neoplasia
Elyzabeth A. Portari et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2013)
Dosage of Dyrk1a Shifts Cells within a p21-Cyclin D1 Signaling Map to Control the Decision to Enter the Cell Cycle
Jia-Yun Chen et al.
MOLECULAR CELL (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Preoperative axillary staging in breast cancer patients: repeat sampling in cases of suspicious ultrasound or inconclusive cytology
L. Clarke et al.
BREAST CANCER RESEARCH (2013)
Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer
G. Smith et al.
BRITISH JOURNAL OF CANCER (2012)
LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker
Dahu Chen et al.
NATURE MEDICINE (2012)
NON-CODING RNA MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship
Amy E. Pasquinelli
NATURE REVIEWS GENETICS (2012)
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
John M. Lamar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Role of GLI2 in the growth of human osteosarcoma
Hiroko Nagao et al.
JOURNAL OF PATHOLOGY (2011)
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
X. Zhang et al.
ONCOGENE (2011)
E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components
Nam-Gyun Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Up-regulation of cyclin D1 by JNK1/c-Jun is involved in tumorigenesis of human embryo lung fibroblast cells induced by a low concentration of arsenite
Yuan Li et al.
TOXICOLOGY LETTERS (2011)
Sonic Hedgehog Signaling Induces Vascular Smooth Muscle Cell Proliferation via Induction of the G1 Cyclin-Retinoblastoma Axis
Fenghe Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
Chad A. Hall et al.
CANCER RESEARCH (2010)
The Cancer/Testis Antigen CAGE with Oncogenic Potential Stimulates Cell Proliferation by Up-regulating Cyclins D1 and E in an AP-1-and E2F-dependent Manner
Elaine Por et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
p27Kip1 Mediates Addiction of Ovarian Cancer Cells to MYCC (c-MYC) and Their Dependence on MYC Paralogs
Tulsiram Prathapam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation
Africa Fernandez-L et al.
GENES & DEVELOPMENT (2009)
Human Synapsin I Mediates the Function of Nuclear Respiratory Factor 1 in Neurite Outgrowth in Neuroblastoma IMR-32 Cells
Jen-Ling Wang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Tumor suppressor LATS1 is a negative regulator of oncogene YAP
Yawei Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor I as a prognostic marker for advanced-stage serous ovarian adenocarcinomas
Michael J. Birrer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Clustering of DNA sequences in human promoters
PC FitzGerald et al.
GENOME RESEARCH (2004)
Share Paper
